A recent study supported by Galderma reveals that 56% of women mistakenly attribute skin changes during menopause to general aging rather than recognizing them as menopause-related. The survey found that only 29% identified the link to menopause, highlighting what Galderma terms 'The Menopausal Skin Misread.'
Read More
The findings indicate a significant knowledge gap, as one in two women are unaware that hormonal fluctuations during perimenopause and menopause can impact skin condition. Furthermore, 82% of participants believe that increased awareness about the differences between menopause-related changes and general aging would empower them in their skincare decisions.
Dr. Andreas Nikolis led an investigator-initiated trial demonstrating that a sequenced approach using Restylane Skinboosters followed by Sculptra significantly improved hydration and remodeling in the skin of menopausal women. The study compared two treatment sequences and found that starting with Restylane Skinboosters yielded a 27.3% increase in dermal thickness, compared to 15.7% with Sculptra used first.
The study's results suggest that addressing menopausal skin issues requires a different approach than traditional aging narratives. Dr. Nikolis emphasized the importance of creating a regimen that combines immediate hydration with long-term collagen production.
Galderma plans to launch a new campaign, 'Rewriting the Future of Your Skin, Own Your Menopause Story,' ahead of World Menopause Day on October 18. This initiative aims to enhance dialogue on the impact of hormonal changes, providing clearer information for women navigating menopause-related skin transformations.
The survey, conducted by Perspectus Global, gathered data from 5,090 women across the UK, US, Brazil, and China from August 25 to September 1, 2026, aiming to bridge the educational gap in the conversation about menopausal skin changes.